Drew Altman, in The Wall Street Journal’s Think Tank, considers a question for the news media: how much Affordable Care Act political coverage is too much?
- view as grid
- view as list
This blog post discusses Sovaldi (sofosbuvir), an oral drug recently approved by the FDA for the treatment of chronic hepatitis C, and the potential impact of this long-awaited cure on Medicare spending and Part D premiums.
Drew Altman, in The Wall Street Journal’s Think Tank, discusses how the Department of Veterans Affairs health system scandal creates an opportunity for a fix, maybe with bipartisan support.
Drew Altman, in The Wall Street Journal’s Think Tank, discusses the push by Conservative House Republicans for a vote on a GOP health care plan and uses public opinion polling to explain the push as an appeal to the Republican base in an election year.
Drew Altman, in The Wall Street Journal’s Think Tank, discusses “what lessons NOT to learn” from the recent healthcare.gov and VA health care failures.
Drew Altman, in The Wall Street Journal’s Think Tank, examines the tradeoff between choice of doctors and hospitals and price when choosing a narrow network.
Drew Altman, in The Wall Street Journal‘s Think Tank, writes that the next big concern for the Affordable Care Act (ACA) will be how much premiums increase in exchanges for 2015. He discusses the factors to focus on to put this issue in perspective when states report premium increases.
Drew Altman, in The Wall Street Journal’s Think Tank, examines a study finding Massachusetts’ health reform saved lives in the context of health insurance’s twin goal: better access to improve health and economic security.
Drew Altman, in The Wall Street Journal’s Think Tank, discusses how the conversation will soon shift back to health-care costs from health coverage, because they are rising more sharply again. And as the discussion turns back, he says that because there is no national agreement on a strategy to address increasing costs, current efforts in the public and private sector, however fragmented and uncoordinated, will need to step up their game.
This Policy Insight explores possible explanations for the continued rise in Medicare Advantage enrollment between 2010 and 2013 in spite of a projected decrease following payment changes in the Affordable Care Act (ACA).